COLL · Collegium Pharmaceutical, Inc.

Summary

Shareholders elected eight directors and approved executive compensation and auditor ratification at the 2026 Annual Meeting.

Key takeaways

• All eight director nominees were elected with strong support, each receiving over 26 million votes.
• Advisory vote on executive compensation passed with 26.3 million votes for and 1.1 million against.
• Ratification of Deloitte as auditor for fiscal 2026 was approved with 28.95 million votes for.
• A total of 29.2 million shares were voted out of 32.4 million entitled shares, representing 90% turnout.